title: HIV Pre-Exposure Prophylaxis - Is it just about pills?
abstract: The increasing use of antiretrovirals for averting HIV infection before potential exposure is under debate. Whereas there is no doubt about the benefit of using Truvada® (tenofovir plus emtricitabine) to reduce HIV acquisition in uninfected persons who have sex with HIV-infected stable partners, concerns are rising about the increasing rate of sexually transmitted infections in subjects engaged in sex with multiple partners, due to misinterpreted self-security.
authors.affiliation: Infectious Diseases Unit, University Hospital Crosshouse, Kilmarnock, Scotland.
authors.forename: Jose V
authors.initials: JV
authors.lastname: Fernandez-Montero
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006078:Government Programs; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D010353:Patient Education as Topic; D065129:Pre-Exposure Prophylaxis / Q000379:methods*; D012307:Risk Factors; D047568:Unsafe Sex
chemical_list: D019380:Anti-HIV Agents